
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Ginkgo biloba extract standardized to 24% flavonoid glycosides and 6% terpene lactones improves cerebral blood flow by inhibiting platelet-activating factor and enhancing nitric oxide production. Clinical studies demonstrate 7-12% improvements in cognitive performance and circulation parameters.

Reported Benefits (Provisional)
Origin & History

Ginkgo biloba is derived from the leaves of the Ginkgo tree, native to China. The extract is standardized to contain 24% flavone glycosides and 6% terpene lactones. It is produced through a process of drying and extracting the active compounds from the leaves.
Research Narrative (Provisional)
Numerous RCTs and meta-analyses support its efficacy in improving cognitive function and circulation. Studies also indicate potential benefits in reducing anxiety symptoms.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Contains flavonoids and terpenoids. - Rich in antioxidants. - Contains bilobalide and ginkgolides.
Reported Mechanism (Provisional)
The standardized extract's flavonoid glycosides (quercetin, kaempferol) and terpene lactones (ginkgolides A, B, C and bilobalide) inhibit platelet-activating factor (PAF) and enhance nitric oxide synthase activity. This dual action reduces blood viscosity while promoting vasodilation through increased cGMP levels. The ginkgolides specifically antagonize PAF receptors, preventing excessive platelet aggregation and improving microcirculation.
Clinical Narrative (Provisional)
Multiple randomized controlled trials involving over 2,000 participants demonstrate ginkgo's cognitive benefits, with studies showing 7-12% improvements in memory tests and attention span over 12-24 weeks. A meta-analysis of 40 studies found significant improvements in claudication distance (walking ability) by an average of 34 meters. However, large-scale trials for dementia prevention have shown mixed results, with some studies finding no significant difference versus placebo in preventing cognitive decline.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







